McNeil recalls some Infants’ Tylenol due to dosing system complaints
Fort Washington, PA, United States (AHN) – McNeil Consumer Healthcare, a division of McNeil-PPC, Inc., is voluntarily recalling at the wholesale and retail levels seven lots, comprising approximately 574,000 bottles, of Infants’ Tylenol Oral Suspension, 1 oz. grape distributed nationwide in the United States.
Infants’ Tylenol is an over-the-counter product indicated as a pain reliever/fever reducer.
McNeil is initiating this voluntary recall as a precaution after receiving a small number of complaints from consumers who reported difficulty using the Infants’ Tylenol SimpleMeasure dosing system.
SimpleMeasure includes a dosing syringe that a parent or caregiver inserts into a protective cover, or “flow restrictor,” at the top of the bottle to measure the proper dose.
In some cases, the flow restrictor was pushed into the bottle when inserting the syringe. Children’s Tylenol products are intended for children two years of age and older and remain available.
No adverse events associated with this action have been reported to date and the risk of a serious adverse medical event is remote.
Consumers can continue to use Infants’ Tylenol provided the flow restrictor at the top of the bottle remains in place.
If the flow restrictor is pushed into the bottle, the parent or caregiver should not use the product.
Consumers can request a refund by visiting www.tylenol.com disclaimer icon or contacting McNeil at 1-888-222-6036 Monday-Friday from 8 a.m. to 8 p.m. Eastern Time; Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time.
Parents and caregivers with any health questions or concerns should contact their healthcare provider and visit www.tylenol.com disclaimer icon for additional information.
View full post on Company Information Stories
Comments Off
